Last $1.42 USD
Change Today -0.27 / -15.98%
Volume 2.7M
As of 5:20 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Spiro George Rombotis

Chief Executive Officer, President and Executive Director, Cyclacel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 2 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Spiro George Rombotis serves as President of Cyclacel Pharmaceuticals Inc. (formerly, Cyclacel Group Plc) and has been its Founding Chief Executive Officer since joining in August 1997. Mr. Rombotis also serves as Chief Executive of Cyclacel Limited. He has over 23 years of experience with pharmaceutical and biotechnology companies. He served as Chief Executive Officer and President of Xcyte Therapies Inc. Previously, he served as Vice President of International ...

Read Full Background

Corporate Headquarters*

200 Connell Drive
Berkeley Heights, New Jersey 07922

United States

Phone: 908-517-7330
Fax: 866-271-3466

Board Members Memberships*

Board Member
Chief Executive Officer, President and Executive Director
Former Chief Executive Officer, President and Director


Williams College
Master's Degree
J.L. Kellogg School of Management, Northwestern University
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$713,414

Stock Options*

All Other Compensation$28,888
Exercisable Options94,869
Exercisable Options Value$20,143
Unexercisable Options107,678
Total Value of Options$20,143
Total Number of Options202,547

Total Compensation*

Total Annual Cash Compensation$742,302
Total Short Term Compensation$713,414
Other Long Term Compensation$28,888
Total Calculated Compensation$1,129,543
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYCC:US $1.42 USD -0.27


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYCLACEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at